Element Materials Technology has acquired Avomeen, a pharmaceutical analytical testing company, significantly expanding the Group’s Life Sciences business unit in North America. Avomeen focuses on pharmaceutical testing, biotechnology and FDA regulated consumer products with a team of 80 scientists and experts. Avomeen enhances Element’s expertise across a wide range of scientific disciplines, bolstering its offering in key strategic growth areas, including formulation chemistry, product...